Brain monoamines are important regulators of affective and cognitive processes and are involved in the aetiology of a number of psychiatric disorders. While methods to probe serotonin and catecholamine function are established, limited methods are available to probe monoamine function as a whole in humans. In the current study, we examined if simultaneous depletion of monoamine precursors can be used as a possible probe of monoamine function. Ten healthy subjects were tested under two treatment conditions; balanced control (B) condition and combined monoamine depletion (CMD) condition. Monoamine precursor depletion was associated with significant reductions in plasma-free tryptophan (46 %), tyrosine (74 %) and phenylalanine (78 %). Greater reductions were achieved for ratios of each precursor to other large neutral amino acids (LNAA); tryptophan/LNAA (86 %), tyrosine/LNAA (94 %) and phenylalanine/ LNAA (94 %). Findings suggest that simultaneous depletion of monoamine precursors can achieve significant plasma monoamine depletion in the range expected to affect brain monoamine function.
Introduction
Monoamine transmitters, serotonin (5-HT), noradrenaline (NA) and dopamine (DA) are important regulators of affective and cognitive processes. This relationship is especially relevant in many psychiatric disorders, particularly depression and related neurotic illnesses, where abnormalities in central monoamine pathways are suggested to contribute to mood and cognitive impairments associated with these disorders.
In recent years, there has been renewed interest to develop procedures that challenge monoaminergic systems in humans (Reilly et al., 1997) . A method that is emerging as a popular probe for studying brain monoamines is amino-acid (AA) depletion, which is based on acute precursor restrictions to reduce endogenous neurotransmitter release (Harrison et al., 2002; Reilly et al., 1997; Young et al., 1985) . The procedure involves participants ingesting a suspension of AAs lacking either tryptophan (Trp) (i.e. for depletion of 5-HT), or tyrosine (Tyr) and phenylalanine (Phe) (i.e. for depletion of catecholamines). Depletion is achieved by a combination of (1) increased protein synthesis (which removes these precursors from the blood) and (2) increased competition with other large neutral amino acids (LNAAs) for active precursor transport into the brain (Reilly et al., 1997) . In humans, Trp depletion has been shown to decrease plasma Trp levels by as much as 90 % over 5-6 h (Reilly et al., 1997) , along with substantial declines in 5-HT metabolites (Carpenter et al., 1998 ) and brain 5-HT synthesis (Nishizawa et al., 1997) . Similarly Tyr/Phe depletion has been shown to decrease plasma Tyr and Phe levels in humans (Moja et al., 1996) , and catecholamine metabolites (Palmour et al., 1998) and catecholamine synthesis in animals (McTavish et al., 1999) .
While Trp and Tyr/Phe depletion methods have been used to examine 5-HT and catecholamine function respectively in normal and psychiatric populations, there have been many inconsistencies. For example Trp depletion studies in patients with depression does not fully support the classic monoamine hypothesis of major depressive disorder (Delgado, 2000) , as mood changes are not consistently observed (Moore et al., 2000) . While failure to find consistent mood changes may be explained by several hypotheses (Reilly et al., 1997; Van der Does, 2001) , there is increasing experimental and clinical evidence for complex interactions between monoaminergic systems (Mongeau et al., 1997) . In addition, most psychotropic and antidepressant drugs, while having primary effects on either 5-HT, NA, or DA receptors and/or transporters, often have secondary effects leading to modulation of all monoaminergic systems (Delgado, 2000) . Recently it has been suggested that 5-HT and catecholamine systems may act on common brain regions and/or have common post-synaptic effects related to depressive symptomatology (Bremner et al., 2003) . Therefore, it is possible that simultaneous depletion of 5-HT, and catecholamines may serve as a better probe of monoamine function to examine ; (1) mood and cognitive processes in healthy subjects and patients with mood disorders and (2) identify likely responders to antidepressant drugs.
Accordingly two studies using a combination of a-methyl-para-tyrosine (AMPT) with Trp depletion have examined the effects of simultaneous 5-HT and catecholamine depletion on mood and clinical symptoms (Berman et al., 2002; Salomon et al., 1997) . However this method involved 2-4 d of sequential testing and an overnight stay, making it an inconvenient and demanding experimental probe of monoamine function in humans. In the current study, we examined if an alternative method (i.e. simultaneous depletion of monoamine precursors) can be used as a possible probe of monoamine function in humans. Simultaneous monoamine precursor depletion was performed using a modified method of Young et al. (1985) . In the current method, depletion of monoamines was achieved by removal of Trp, Tyr and Phe from the balanced AA mixture.
Methods

Subjects
Ten healthy female participants [aged 18-30 yr (mean¡S.D., 22.2¡3.6 yr)] were recruited for the study. Subjects were drug free and had no history of any physical or psychiatric conditions as assessed by a medical examination. All subjects gave written informed consent to take part in the study, which was approved by the Swinburne University Human Research Ethics Committee.
Design
The study was a randomized, double-blind, placebocontrolled design in which subjects were tested under two treatment conditions ; the balanced control (B) condition and the combined monoamine precursor depletion (CMD) condition. Treatment conditions were separated by a 5-d washout period.
AA mixture
The AA bolus used in the current study was modified, based on the 100 g balanced mixture developed by Young et al. (1985) , which was adapted to an 86 g suspension and capsules to account for the lower body weight of women (Leyton et al., 1999) . The B condition included the following AA : L-alanine, 4.58 g; L-arginine, 4.08 g; L-cystine, 2.25 g; L-glycine, 2.97 g; L-histidine, 2.67 g; L-isoleucine, 6.67 g; L-leucine, 11.25 g; L-lysine monohydrochloride, 9.17 g; L-methionine, 2.50 g; L-proline, 10.17 g; L-valine, 7.42 g; Lserine, 5.75 g; L-threonine, 5.42 g; L-Trp, 1.92 g; L-Tyr, 1.75 g ; L-Phe, 4.75 g. Methionine, cystine, and arginine were given in capsules due to their unpleasant taste. In the CMD condition all AA were included except for Trp, Tyr and Phe. Drinks were prepared by mixing the powdered AAs with 180 ml of orange juice within a few minutes of ingestion following administration of the capsules.
Procedure
Testing was conducted during the follicular phase of the menstrual cycle (days 1 -13). On each testing day subjects arrived at 08:30 hours after following a lowprotein diet, and fasting from 19:00 hours on the day prior to testing. A low-protein diet and fasting was required, as it has been suggested that it may enhance the effect of monoamine depletion and reduce the variability in baseline 5-HT levels (Reilly et al., 1997) . A baseline blood sample was first obtained, followed by the ingestion of the AA drink and capsules. A second blood sample was obtained again 5 h after ingestion of the AA load. Side-effects were monitored using a symptom check-list that included headache, cold, hot, dizziness, sweating, blurred vision, nausea, heart palpitations, dry mouth, and gastric complaints.
AA measurement
Concentrations of free AAs Trp, Tyr, Phe, valine (Val), leucine (Leu), and isoleucine (Ile) in plasma were determined using precolumn derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) followed by separation of the derivatives and quantification by reversed-phase high-performance liquid chromatography (RP-HPLC) (Cohen, 2001 ). All AAs except Trp were detected by fluorescence, while Trp required UV detection. Val, Leu and Ile levels were analysed to calculate the ratio of plasma Trp, Tyr, or Phe, to other LNAAs.
Prior to derivatization, the plasma samples (100 ml) were diluted 1 :1 with internal standard solution and deproteinized by ultrafiltration through a membrane with a 10 kDa nominal molecular weight cut-off (Ultrafree MC with PL-10 membrane, Millipore, MA, USA). The filtrate (100 ml) was then subjected to AQC derivatization and HPLC analysis using the Waters AccTag AA analysis system (Waters Corporation, Milford, MA, USA) (Cohen, 2001 ).
Statistical analysis
Data was analysed using repeated-measures ANOVAs with time (pre-treatment scores, 0 h vs. post-treatment scores, 5 h) and treatment (B or CMD) as the group factors. Free AA (Trp, Tyr, Phe, Leu, Ile, Val) were analysed using a 6 (AA)r2 (treatment : B, CMD)r2 (time: pre-and post-treatment) repeated-measures ANOVA. In addition, plasma-ratio data was analysed using a 3 (AA ratio : Trp: S LNAAs, Tyr :S LNAAs, Phe: S LNAAs) r 2 (treatment) r 2 (time) repeatedmeasures ANOVA.
Results
AA levels ( mmol/l)
There was a significant 6 (AA)r2 (time)r2 (treatment) repeated-measures ANOVA interaction [F(1.49, 11.93) =12.86, p<0.001 ; Greenhouse-Geisser adjusted], indicating that treatment modified the effect of time on AA concentration levels. In order to further investigate this effect, we conducted two 6 (AA)r2 (time) repeatedmeasures ANOVAs. Results indicated a significant AArtime interaction for both the B condition [F(1.91, 17.19 )=64.04, p<0.001; Greenhouse-Geisser adjusted], and for the CMD condition [F(1.14, 9.98)= 87.88, p<0.001 ; Greenhouse-Geisser adjusted]. Following administration of the B condition, all concentrations of the 6 AAs increased significantly (all pf0.001) compared to baseline. Following administration of the CMD condition, Trp, Tyr and Phe levels decreased significantly (all p<0.001) compared to baseline, whilst the remaining AA concentrations increased significantly (all p<0.001) compared to baseline (Table 1) .
There was a significant interaction between 3 (AA ratio) r 2 (time) r 2 (treatment) repeated-measures ANOVA interaction [F(1.16, 10 .45)=18.99, p=0.001; . The ratio of Trp: S LNAAs, Tyr :S LNAAs and Phe :S LNAAs was significantly reduced in the B condition, however a much greater reduction in the same ratios was observed in the CMD condition (Table 1) .
Side-effects
No significant adverse effects were found between the B and CMD conditions as assessed with a symptom check-list that included the following ; headache, cold, hot, dizziness, sweating, blurred vision, nausea, heart palpitations, dry mouth, and gastric complaints ( Table 2) .
Discussion
The present study examined if simultaneous depletion of Trp, Tyr and Phe can induce significant depletions of their plasma concentrations. Our findings suggest that plasma levels of all three monoamines were significantly reduced to levels that are expected to affect central monoamine function. In addition, no significant side-effects were reported in comparison to the B condition making its use as an experimental method in humans desirable.
Compared to studies using single depletion (i.e. Trp depletion), which have been found to induce depletions in the range of 60-92 % (for a table of depletion levels of previous studies see reviews by Moore et al., 2000 and Van der Does, 2001) , only a modest depletion of free Trp (46 %) was achieved in the current study using the CMD method. However, the Trp/ LNAA ratio was depleted by 86 %, which was comparable to that achieved using the Trp depletion method (79-95 %) (Leyton et al., 2000; Schmitt et al., 2000) . The latter finding is of importance given that the Trp/LNAA ratio has been suggested to be a more accurate indicator of brain 5-HT concentrations (Fernstrom et al., 1979; Oldendorf and Szabo, 1976) and has recently been recommended as an important index for inclusion in future studies of this nature (Van der Does et al., 2001) . Although the magnitude of free Trp depletion using this method was only approximately half of that reported in previous Trp depletion studies that show substantial declines in measures of 5-HT function such as 5-HT metabolites (85 % depletion) (Carpenter et al., 1998 ) and brain 5-HT synthesis (83 % depletion) (Nishizawa et al., 1997) , no studies have linked the ratio of Trp/LNAA to these measures of 5-HT function. While it is difficult to establish the extent to which the CMD method affected central serotonergic function, it is possible given that the ratio of Trp/LNAA was depleted by 86 % (which has been suggested to be a better indicator of central 5-HT depletion) that one could expect changes to 5-HT function following the CMD method.
Depletion of plasma Tyr and Phe concentrations (74-78 %) and Tyr/LNAA and Phe/LNAA ratios (94 %) in the CMD method was similar in magnitude to that observed in previous studies using the Tyr/ Phe depletion method (plasma Tyr/Phe: 53-76 % depletion ; Tyr/Phe to LNAA ratio : 99 % depletion) (Harmer et al., 2001; Leyton et al., 2000) . Previous studies in animals with Tyr depletion between 30 and 40 %, have shown significant reductions in catecholamine metabolites (Palmour et al., 1998) and catecholamine synthesis in the brain (McTavish et al., 1999) . In humans, depletion of Tyr/Phe to a similar magnitude to that observed in the CMD method impaired DArelated spatial working-memory function (Harmer et al., 2001) . Hence the level of depletion obtained using the CMD method would be expected to affect central catecholamine function. The B condition also decreased Trp, Tyr and Phe to LNAA ratios by 28-33 % and hence the control condition could be considered a relatively conservative one. However, the magnitude of reduction observed with the B condition is in the same range as that observed in other studies (Harmer et al., 2001; Leyton et al., 2000) . It has also been suggested that the observed magnitude of changes are within the normal expected range of monoamine precursor/LNAA ratios due to diurnal changes and normal variation in protein intake (Fernstrom et al., 1979) . It is, therefore, likely that any changes of this magnitude resulting from normal diurnal changes in precursor availability would be expected to cause changes within the normal variability of central 5-HT and catecholamine function.
There is increasing evidence for complex interactions between monoaminergic systems (Mongeau et al., 1997) and these systems play an important role in the pathophysiology of a number of psychiatric disorders (Delgado, 2000) . Single depletion methods such as Trp depletion and Tyr/Phe depletion have limitations in that they only target 5-HT or catecholamine function respectively. This may explain the inconsistent findings observed in previous studies examining mood or clinical symptoms (Moore et al., 2000) . Interestingly, Trp depletion and AMPT has been shown to reduce blood flow in overlapping brain areas suggesting that both the serotonergic and catecholamine systems may have common neurochemical and/or neuroanatomical effects related to depressive symptomatology (Bremner et al., 2003) . The CMD method could be a useful experimental probe to examine the effects of both the serotonergic and catecholaminergic systems in relation to mood, clinical symptoms and cognition in healthy controls, subjects with genetic vulnerability to mood disorders and patients with psychiatric disorders. Furthermore as with Trp depletion and AMPT methods (Bremner et al., 2003) , the CMD method may be useful in identifying responders to particular antidepressant drug classes. We have recently shown in healthy subjects that simultaneous depletion of monoamines using this method has selective effects on mood (Hughes et al., 2004) and impairs sustained attention without affecting learning or memory (Matrenza et al., In Press) . These findings indicate that the CMD method can induce behavioural effects highlighting its usefulness as an experimental method to examine monoamine function in humans.
The CMD method may have several advantages over the method combining AMPT with Trp depletion. It is more convenient and less demanding (the CMD method only takes 5-6 h compared to the 2-4 d with overnight stays required with the latter method) and has been shown to have behavioural sensitivity on measures of mood (Hughes et al., 2004) and cognition (Matrenza et al., In Press) in comparison to the latter method (Salomon et al., 1997; Berman et al., 2002) . While it is difficult to directly compare the extent of 5-HT and catecholamine depletion obtained using both methods due to differences in biochemical measures of 5-HT or catecholamine function, both methods induced moderate changes in free Trp or Trp/LNAA ratio (i.e. 46 % depletion of free Trp and 86 % depletion of Trp/LNAA in the CMD method compared to 55-78 % depletion of free Trp in the latter method). Similarly, both methods induced significant depletion or reductions in measures of catecholamine function (74-78 % depletion of plasma Tyr/Phe and 94-99 % depletion of Tyr/Phe to LNAA ratio in the CMD method and 63 % reduction in plasma homovanillic acid in the latter method).
In summary, the current study suggests that simultaneous depletion of monoamine precursors Trp, Tyr and Phe using the CMD method can achieve significant plasma monoamine depletion in the range expected affect central monoamine function, suggesting that it may be a useful and safe experimental method to probe monoamine function in humans.
